2012
DOI: 10.1016/j.joms.2011.09.012
|View full text |Cite
|
Sign up to set email alerts
|

Ameloblastic Fibrosarcoma: Report of a Case, Study of Immunophenotype, and Comprehensive Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
3
4

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 34 publications
(39 citation statements)
references
References 34 publications
0
30
3
4
Order By: Relevance
“…On imaging, the tumor is a destructive expansile radiolucent jaw mass with ill-defined borders. Interestingly, about half of these tumors arise in a recurrence of a previous AF and the mean age of AF is about 10 years younger (14.6 years) than for AFS [37][38][39]. ARS is considered a locally aggressive neoplasm with a low incidence of metastasis (4 %).…”
Section: Ameloblastic Fibrosarcoma (Afs)mentioning
confidence: 99%
“…On imaging, the tumor is a destructive expansile radiolucent jaw mass with ill-defined borders. Interestingly, about half of these tumors arise in a recurrence of a previous AF and the mean age of AF is about 10 years younger (14.6 years) than for AFS [37][38][39]. ARS is considered a locally aggressive neoplasm with a low incidence of metastasis (4 %).…”
Section: Ameloblastic Fibrosarcoma (Afs)mentioning
confidence: 99%
“…AFS is the most common of them (66,(114)(115)(116)(117). In Brazilian series, the reported frequency of AFS is up to 1.0% of OTs (3,(117)(118)(119)(120) The WHO's odontogenic tumor classification describes AFS as being of primary (de novo lesion) and secondary (from benign AF) types (1,4,5). Because of the secondary types (88), initial diagnosis of a malignant phenotype is not always easy.…”
Section: Discussionmentioning
confidence: 99%
“…Results obtained from several papers (4,5,69,79,82,88,89,113) revealed that Ki-67 was overexpressed (highly diffuse positivity) in the malignant mesenchymal portion of AFS, compared with AF. When Ki-67 was quantified, positivity rates ranged from 13.5% to 60.0% for the malignant mesenchymal component.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations